temoporfin has been researched along with lactic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engel, A; Knobloch, T; Langer, K; Löw, K; von Briesen, H; Wagner, S; Wiehe, A | 1 |
Hackbarth, S; Knobloch, T; Langer, K; Preuss, A; Röder, B; Wacker, M | 1 |
Bovis, MJ; Celotti, L; Compagnin, C; Helfrich, W; Kocbek, P; Kos, J; Macrobert, AJ; Moret, F; Papini, E; Reddi, E; Rojnik, M; Scheglmann, D; Verkaik, MJ; Woodhams, JH | 1 |
Chandran, P; Gupta, N; Koyakutty, M; Malarvizhi, GL; Nair, S; Ramachandran, R; Retnakumari, AP | 1 |
4 other study(ies) available for temoporfin and lactic acid
Article | Year |
---|---|
Comparison of intracellular accumulation and cytotoxicity of free mTHPC and mTHPC-loaded PLGA nanoparticles in human colon carcinoma cells.
Topics: Bromodeoxyuridine; Cell Death; Cell Membrane; Cell Proliferation; Cell Survival; Chemical Phenomena; Colonic Neoplasms; Flow Cytometry; HT29 Cells; Humans; Intracellular Space; Lactic Acid; Mesoporphyrins; Microscopy, Confocal; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Spheroids, Cellular | 2011 |
Comprehensive in vitro investigations on biodegradable photosensitizer-nanoparticle delivery systems.
Topics: Drug Delivery Systems; Humans; Jurkat Cells; Lactic Acid; Mesoporphyrins; Nanoparticles; Photochemotherapy; Photosensitizing Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Serum Albumin | 2010 |
In vitro and in vivo characterization of temoporfin-loaded PEGylated PLGA nanoparticles for use in photodynamic therapy.
Topics: Animals; Cell Line, Tumor; Drug Delivery Systems; Humans; Lactic Acid; Mesoporphyrins; Mice; Mice, Nude; Nanoparticles; Photochemotherapy; Polyethylene Glycols; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2012 |
A rationally designed photo-chemo core-shell nanomedicine for inhibiting the migration of metastatic breast cancer cells followed by photodynamic killing.
Topics: Breast; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Dasatinib; Drug Carriers; Female; Humans; Lactic Acid; Mesoporphyrins; Molecular Docking Simulation; Nanomedicine; Neoplasm Metastasis; Photochemotherapy; Photosensitizing Agents; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Protein-Tyrosine Kinases; Pyrimidines; Serum Albumin; Thiazoles | 2014 |